A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 600,400 shares of CODX stock, worth $804,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600,400
Previous 617,000 2.69%
Holding current value
$804,536
Previous $821,000 18.15%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$1.06 - $1.42 $17,596 - $23,572
-16,600 Reduced 2.69%
600,400 $672,000
Q4 2023

Feb 13, 2024

SELL
$1.0 - $1.5 $19,400 - $29,100
-19,400 Reduced 3.05%
617,000 $821,000
Q3 2023

Nov 14, 2023

SELL
$1.03 - $1.85 $17,819 - $32,005
-17,300 Reduced 2.65%
636,400 $675,000
Q2 2023

Aug 11, 2023

BUY
$1.04 - $1.64 $5,616 - $8,856
5,400 Added 0.83%
653,700 $726,000
Q1 2023

May 12, 2023

SELL
$1.39 - $3.24 $8,201 - $19,116
-5,900 Reduced 0.9%
648,300 $959,000
Q4 2022

Feb 13, 2023

SELL
$2.32 - $3.68 $117,391 - $186,208
-50,600 Reduced 7.18%
654,200 $1.65 Million
Q3 2022

Nov 14, 2022

BUY
$2.87 - $7.01 $61,131 - $149,313
21,300 Added 3.12%
704,800 $2.26 Million
Q2 2022

Aug 12, 2022

BUY
$3.76 - $6.29 $366,404 - $612,947
97,448 Added 16.63%
683,500 $3.83 Million
Q1 2022

May 13, 2022

BUY
$5.03 - $9.61 $1.47 Million - $2.8 Million
291,552 Added 99.0%
586,052 $3.62 Million
Q4 2021

Feb 11, 2022

BUY
$8.12 - $10.37 $893,199 - $1.14 Million
110,000 Added 59.62%
294,500 $2.63 Million
Q3 2021

Nov 12, 2021

BUY
$7.48 - $11.38 $921,536 - $1.4 Million
123,200 Added 200.98%
184,500 $1.8 Million
Q2 2021

Aug 13, 2021

BUY
$7.16 - $9.56 $438,908 - $586,028
61,300 New
61,300 $506,000
Q1 2020

May 14, 2020

SELL
$0.91 - $17.81 $14,575 - $285,262
-16,017 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$0.88 - $1.12 $14,094 - $17,939
16,017 New
16,017 $14,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $45.3M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.